Cerebral amyloid PET imaging in Alzheimer’s disease

By Jack Clifford   Barrio Jorge   Kepe Vladimir  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 643-657

Springer Publishing Company

Access to resources Recommend Favorite

Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease

By Wang Yanming   Klunk William   Debnath Manik   Huang Guo-Feng   Holt Daniel   Shao Li   Mathis Chester  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 55-62

Humana Press, Inc

Access to resources Recommend Favorite

The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains

By Gutala R.V.   Reddy P.H.  

Journal of Neuroscience Methods, Vol. 132, Iss. 1, 2004-01 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology

By Gouw A. A.  

Brain, Vol. 131, Iss. 12, 2008-12 ,pp. : 3286-3298

Oxford University Press

Access to resources Recommend Favorite

11 C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

By Jack Clifford R.  

Brain, Vol. 131, Iss. 3, 2008-03 ,pp. : 665-680

Oxford University Press

Access to resources Recommend Favorite